In humans, heterozygous mutations of PLIN1 lead to lipodystrophy, hypercholesterolemia and FLD [27], most probably via impaired perilipin 1-driven lipolysis in adipose tissue. The gene discussed is PLIN1; the disease is lipodystrophy.